Literature DB >> 15019872

Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia.

Junko Asada1, Hisako Tsuji, Toshiji Iwasaka, James D Thomas, Michael S Lauer.   

Abstract

Plasma brain natriuretic peptide (BNP) levels have been associated with left ventricular dysfunction and acute myocardial infarction. Although natriuretic peptide responses have been linked to exercise-induced myocardial ischemia, it is not known whether BNP levels predict dobutamine-induced myocardial ischemia. The aim of this study was to determine whether elevations in BNP levels immediately before or after dobutamine-induced stress are associated with echocardiographic myocardial ischemia. Plasma BNP was measured before and after stress during dobutamine-stress echocardiography in 317 patients (aged 68 +/- 11 years; 46% women) who had creatinine <1.5 mg/dl and did not have valvular disease. Ischemia, as assessed by blinded echocardiographic interpretation, was noted in 31 patients (10%). In univariable analyses, prestress BNP was predictive of echocardiographic ischemia (rates of ischemia according to tertiles of BNP 4%, 9%, and 16%, chi-square for trend = 8, p = 0.0059). The change in BNP levels with dobutamine stress was not associated with ischemia. In multivariable analyses, after adjusting for age, gender, and left ventricular ejection fraction, BNP before and after stress remained predictive of ischemia (1 SD increase in the log of resting BNP adjusted odds ratio 2.0, 95% confidence interval 1.3 to 3.0, p = 0.002). In this pilot study, resting BNP was predictive of dobutamine-induced ischemia. Future work is needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019872     DOI: 10.1016/j.amjcard.2003.11.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.

Authors:  Aylin Yildirir; Sadik Acikel; Cagatay Ertan; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  Tex Heart Inst J       Date:  2007

2.  B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes.

Authors:  B S Rana; J I Davies; M M Band; S D Pringle; A Morris; A D Struthers
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

3.  Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study.

Authors:  Hafid Ait-Oufella; Pierre-Louis Tharaux; Jean-Luc Baudel; Sophie Vandermeersch; Pascal Meyer; Marc Tonnellier; Jean-Claude Dussaule; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Intensive Care Med       Date:  2007-04-03       Impact factor: 17.440

4.  Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies.

Authors:  Bao-Li Zhu; Takaki Ishikawa; Tomomi Michiue; Dong-Ri Li; Dong Zhao; Sayaka Tanaka; Yasunobu Kamikodai; Kohei Tsuda; Shuji Okazaki; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2006-06-02       Impact factor: 2.686

5.  B-type natriuretic peptide in reversible myocardial ischaemia.

Authors:  K Chatha; M Alsoud; M J Griffiths; A Elfatih; K Abozguia; R C Horton; S J Dunmore; R Gama
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

6.  N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.

Authors:  Gerald Vanzetto; Peggy Jacon; Alex Calizzano; Yannick Neuder; Patrice Faure; Daniel Fagret; Jacques Machecourt
Journal:  J Nucl Cardiol       Date:  2007-10-18       Impact factor: 5.952

7.  B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans.

Authors:  Domingo A Pascual-Figal; María J Antolinos; Antoni Bayes-Genis; Teresa Casas; Francisco Nicolas; Mariano Valdés
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

8.  Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery Disease.

Authors:  C H Hansen; J Cwikiel; V Bratseth; H Arnesen; A Flaa; I Seljeflot
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

9.  NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia.

Authors:  Jacques De Greef; Maryke Funk; William J H Vermaak; Nalini S Perumal; Carlos D Libhaber; Mboyo-Di-Tamba Vangu
Journal:  Cardiovasc J Afr       Date:  2008 Sep-Oct       Impact factor: 1.167

10.  Does dipyridamole-induced ischaemia affect NT-proBNP secretion?

Authors:  Jacques De Greef; Radha Govender; William Vermaak; Nalini Perumal; Elena Libhaber; Mboyo-Di-Tamba Vangu
Journal:  Cardiovasc J Afr       Date:  2007 Nov-Dec       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.